LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$5.40
+0.06 (+1.12%)
Open$5.35
Previous Close$5.34
Day High$5.74
Day Low$5.34
52W High$23.25
52W Low$4.21
Volume—
Avg Volume31.6K
Market Cap8.71M
P/E Ratio—
EPS$-0.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+389.4% upside
Current
$5.40
$5.40
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 63.2K | 45.3K | 9.47M |
| Net Income | -1,066,487 | -688,006 | 1.90M |
| Profit Margin | -1,686.0% | -1,601.7% | 20.1% |
| EBITDA | -1,059,391 | -721,397 | 3.60M |
| Free Cash Flow | — | — | 1.11M |
| Rev Growth | +39.5% | +39.5% | +1.1% |
| Debt/Equity | — | — | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |